Adrenal disorders encompass a wide spectrum of diseases, each with its unique pathophysiology, clinical presentation, and management strategies. This article aims to provide a comprehensive overview of these disorders, highlighting key points for diagnosis and treatment.
The adrenal glands, located superior to the kidneys, consist of two distinct parts: the cortex and medulla. Each part produces different hormones essential for maintaining homeostasis. The cortex produces glucocorticoids, mineralocorticoids, and adrenal androgens, while the medulla secretes catecholamines.
Adrenal insufficiency occurs when the adrenal glands cannot produce sufficient hormones. It can be primary (Addison's disease), secondary due to pituitary dysfunction, or tertiary due to hypothalamic disease. Symptoms are often nonspecific, including fatigue, weight loss, and hypotension. Diagnosis involves baseline cortisol measurement and dynamic testing. Treatment typically involves hormone replacement.
Cushing syndrome is characterized by excess cortisol, leading to weight gain, hypertension, diabetes, and osteoporosis. It can be endogenous (due to adrenal, pituitary, or ectopic tumors) or exogenous (prolonged glucocorticoid use). Diagnosis involves screening tests, such as 24-hour urinary free cortisol, followed by confirmatory tests. Treatment depends on the underlying cause.
Adrenal incidentalomas are adrenal masses discovered incidentally during imaging studies performed for unrelated reasons. Although most are benign and nonfunctional, they require evaluation to rule out malignancy and hormone hypersecretion. Management varies based on size, imaging characteristics, and functionality.
Pheochromocytomas and paragangliomas are rare catecholamine-secreting tumors that can cause severe hypertension. Diagnosis involves biochemical testing for metanephrines, followed by imaging. Surgical resection is the treatment of choice.
Understanding adrenal disorders is crucial for accurate diagnosis and effective management. While some disorders are common and others rare, all require a high index of suspicion, appropriate testing, and individualized treatment strategies. As our understanding of these disorders continues to evolve, so too will our approach to patient care.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation